Resources
The latest in biomarkers research, from development and diagnostics to precision medicine
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Genomic Markers & Precision Medicine
Applications of Spatial Transcriptome Technologies for Monitoring the Molecular Mechanisms of Diseases
Spatial transcriptomics leverages omics techniques to extract transcriptome data while retaining the context of the original tissue, aiding disease research, biomarker development, and understandings of tissue structures and cellular heterogeneity.
Genomic Markers & Precision Medicine
How Multiplexing Could Increase the Availability of Blood Biomarkers for Classifying Neurodegenerative Disorders
Recent studies have used multiplex blood biomarker information from patients to distinguish individual patient subgroups for neurodegenerative diseases, helping to stratify patients by their pathology.
Genomic Markers & Precision Medicine
Patient Stratification: Leveraging Biomarkers for Precision Medicine
Genomic Markers & Precision Medicine
Diagnostic Biomarkers Identified Through Multi-Omic Approaches in Chronic Decline and Crohn’s Disease
Diagnostic biomarkers offer a crucial means of tracking disease spread and progression. Here, we explore their application in age-related diseases, as well as inflammatory diseases such as Crohn’s.
Genomic Markers & Precision Medicine
Biomarkers in Precision Medicine Approaches for Oncology: Overcoming Obstacles to Usage and Uptake
Precision medicine involves tailoring a therapeutic to a patient’s disease: developing precision therapies require an accurate identification of therapeutic targets from available data.
Genomic Markers & Precision Medicine
Clinical Biomarker Trends to Watch in 2023
The identification of novel clinical biomarkers is set to continue, with further research and investment in fields such as next-gen sequencing and miRNA targeting.
Genomic Markers & Precision Medicine
Current Status of Omics-Based Biomarkers
Anna Lyubetskaya, Senior Principal Scientist at Bristol Myers Squibb, leads a discussion on the industry landscape and ‘Current Status of Omics-Based Biomarkers.’
Genomic Markers & Precision Medicine
Almac Diagnostic Services: Always a Move Ahead in Precision Medicine
Subscribe to Our Newsletter
Sign up for our monthly newsletter to
keep up with all things biomarkers